The World Salon is delighted to launch the "Daily Digest", where we handpick must-know news of each sector for our subscribers. In today's fast-paced world, staying informed is paramount, but it is easy to get overwhelmed by the numerous newsletters that bombards your inbox each day. Our solution offers a concise yet comprehensive overview of the most significant developments impacting various industries.
Energy
IEA Releases 2023 Emissions Report– A New Record High:
The IEA released its 2023 CO2 emissions report today. Global total emissions from the energy sector surged to unprecedented levels in 2023, albeit at a slower growth rate (1.1%) compared to 2022. Across the globe, China witnessed the largest increase in emissions (565 Mt), despite its leading position in clean energy additions. ⅓ of China’s emission growth is attributable to the historically low hydroelectric output. (IEA)
States Push for Grid Enhancement Legislation:
Several states are advocating for legislation that mandate utilities to invest in grid-enhancing technologies that accommodate increased power demands on aging infrastructure. Bills aimed at improving the efficiency of the nation's high-voltage transmission system are being considered in state legislatures nationwide. This week, Virginia passed its legislation and a relevant bill got a committee hearing in Minnesota. (E&E News)
New York Ramps Up Offshore Wind Construction:
Despite last year’s major project cancellations, New York State is pushing ahead to achieve 9,000 MW of offshore wind energy by 2035. In its fourth wind solicitation, NYSERDA gave additional awards to Empire Wind 1 and Sunrise Wind, winners in the first wind solicitation in 2019. The projects need to fulfill commitments of $32 million investments in New York’s disadvantaged communities; $16.5 million towards wildlife and fisheries monitoring; and a minimum of $188 million purchase of U.S. iron and steel. (Renewable Energy World)
Technology
Nvidia Leads the New “Gold Rush” in AI:
As Nvidia share value shot up by over 60%, Wall Street is on the hunt for companies capitalizing on breaking AI technology. As AI continues to transform various industries, investors are diversifying their portfolios to include firms across the AI value chain, recognizing the lasting impact that AI has on productivity and growth. Fund managers have branched out their portfolio into ancillary players, such as cybersecurity (Zscaler) and data infrastructure (Snowflake). (Reuters)
OpenAI Sued over “Betrayal” of Founding Mission:
Elon Musk sued OpenAI and its co-founders, accusing them of deviating from the nonprofit’s original mission: the development of AI for humanity's benefit. Musk claims he was misled into funding OpenAI with the understanding that it would make its technology “freely available” to the public. The lawsuit alleges that OpenAI has shifted to a for-profit model after receiving a $13 billion investment from Microsoft. Musk seeks after the court rule that advanced AI models under development (such as GPT-4) are beyond the reach of licensing agreements. (TechCrunch)
Demand for Risk Intelligence under Rising Geopolitical Uncertainty:
Private equity giant Thoma Bravo is set to acquire Everbridge, a critical event management software company that helps governments and enterprises respond to emergencies. The $1.8 billion all-cash deal reflects a premium of over 83% on Everbridge’s market cap. The bid’s high premium underscores the growing importance of risk intelligence in navigating complex geopolitical uncertainties. (TechCrunch)
Health
Animal Lab Issues at Musk’s Neuralink:
The U.S. Food and Drug Administration (FDA) cited problems with Neuralink’s record-keeping practices and quality controls with regards to animal experiments at its California research facility. Despite Neuralink's claim that it was cleared to proceed with testing in humans, the FDA's findings indicate further work is needed to ensure data integrity and compliance with fundamental requirements. (Reuters)
Pfizer's Ambition for Oncology by 2030:
Pfizer announced its ambitious oncology strategy, aiming for at least eight blockbuster cancer drugs by 2030 and a doubling in the number of patients treated with innovative cancer medicines. With the acquisition of Seagen, an antibody-drug conjugate specialist, Pfizer plans to expand manufacturing capacity for breast cancer medicines. The company also seeks to make genitourinary cancer treatments its largest oncology franchise. (Fierce Pharma)
South Korean Trainee Doctors’ Protest Face Pressure from Authorities:
South Korean police conducted a raid on Korean Medical Association (KMA) officials as tensions escalate over a strike. Trainee doctors have been protesting against overwork and underpayment. The KMA denounced the government instruction for the raid, calling it “absurd” and another infringement on doctors' freedom. (Reuters)
Picture Resource:
https://cloudfront-us-east-2.images.arcpublishing.com/reuters/R7KF5PKLJ5OADHUMOEIJTQTUA4.jpg
